Haggen lines up buyers for 10 stores in Tri-Counties
Haggen is looking to sell some of its soon-to-be vacant stores in the Tri-Counties to Gelson’s Markets and Smart & Final pending bankruptcy court approval, the company announced Oct. 5. Gelson’s and Smart & Final got the first pick of 127 shuttering Haggen stores. The high-end Encino-based grocer Gelson’s signed an asset purchase agreement Read More →
Read More →European regulators have good news for Amgen on cancer drugs
One of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →
Read More →FICO score can make a big difference
For most small businesses, the toughest aspect of running the operation is managing cash flow. Most small businesses depend on timely payments from their clients to pay their own bills. However, in difficult times such as these, clients often stretch payment of their invoices to 60 days or longer. In order to be able to Read More →
Read More →Amgen cancer drug Kyprolis to get expedited review from FDA
An experimental multiple myeloma treatment using Amgen’s Kyprolis will get an expedited review from the U.S. Food and Drug Administration. The FDA said it will use an expedited review process to review a multiple-myeloma treatment using Kyprolis and the genric drug dexamethasone. On July 23, Amgen submitted additional data to the FDA which compared this Read More →
Read More →
Ventura County Community Foundation lays off staff, shelves center for nonprofits
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen licenses cancer drug to NatPharma
Amgen has licensed an experimental cancer drug to a Chicago biotech company founded and controlled by billionaire Patrick Soon-Shiong. NatPharma LLC is licensing the rights to AMG 337 from Thousand Oaks-based Amgen to develop and sell AMG 337. The drug is an experimental, phase-two cancer treatment. The licensing agreement is the second between Amgen and Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
